Lung cancer and lung transplantation: A review

Josy Mathew, Robert A Kratzke

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

With the increase in the number of lung transplants, it is expected that there will be a corresponding increase in the number of lung cancers reported in these patients. Longevity of the transplant recipients, lung transplantation for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, a history of smoking, and the increasing age of the lung donors make lung cancer more likely. Nodules and masses seen in chest imaging in lung transplant patients call for work up until a final diagnosis is achieved because there is a high likelihood of a serious infection or malignancy. The presence of a native lung is a major risk factor for lung cancer occurring in the transplant setting. Lung cancer of donor origin is rare. Bronchioloalveolar carcinoma confined to one lung can potentially be treated by transplanting the affected lung. Treatment for patients with lung cancer in the lung transplant setting has to be individualized because of the complexity of their medical problems and multiple medications. Attention needs to be focused on detecting lung cancer early in these patients to achieve a favorable outcome.

Original languageEnglish (US)
Pages (from-to)753-760
Number of pages8
JournalJournal of Thoracic Oncology
Volume4
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Lung Transplantation
Lung Neoplasms
Lung
Transplants
Tissue Donors
Bronchiolo-Alveolar Adenocarcinoma
Idiopathic Pulmonary Fibrosis
Chronic Obstructive Pulmonary Disease
Thorax
Smoking
Infection
Neoplasms

Keywords

  • Bronchioalveolar cancer
  • Lung transplantation
  • NSCLC

Cite this

Lung cancer and lung transplantation : A review. / Mathew, Josy; Kratzke, Robert A.

In: Journal of Thoracic Oncology, Vol. 4, No. 6, 06.2009, p. 753-760.

Research output: Contribution to journalReview article

@article{96a87043d42f49c58f6bb3e98ac32657,
title = "Lung cancer and lung transplantation: A review",
abstract = "With the increase in the number of lung transplants, it is expected that there will be a corresponding increase in the number of lung cancers reported in these patients. Longevity of the transplant recipients, lung transplantation for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, a history of smoking, and the increasing age of the lung donors make lung cancer more likely. Nodules and masses seen in chest imaging in lung transplant patients call for work up until a final diagnosis is achieved because there is a high likelihood of a serious infection or malignancy. The presence of a native lung is a major risk factor for lung cancer occurring in the transplant setting. Lung cancer of donor origin is rare. Bronchioloalveolar carcinoma confined to one lung can potentially be treated by transplanting the affected lung. Treatment for patients with lung cancer in the lung transplant setting has to be individualized because of the complexity of their medical problems and multiple medications. Attention needs to be focused on detecting lung cancer early in these patients to achieve a favorable outcome.",
keywords = "Bronchioalveolar cancer, Lung transplantation, NSCLC",
author = "Josy Mathew and Kratzke, {Robert A}",
year = "2009",
month = "6",
doi = "10.1097/JTO.0b013e31819afdd9",
language = "English (US)",
volume = "4",
pages = "753--760",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "6",

}

TY - JOUR

T1 - Lung cancer and lung transplantation

T2 - A review

AU - Mathew, Josy

AU - Kratzke, Robert A

PY - 2009/6

Y1 - 2009/6

N2 - With the increase in the number of lung transplants, it is expected that there will be a corresponding increase in the number of lung cancers reported in these patients. Longevity of the transplant recipients, lung transplantation for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, a history of smoking, and the increasing age of the lung donors make lung cancer more likely. Nodules and masses seen in chest imaging in lung transplant patients call for work up until a final diagnosis is achieved because there is a high likelihood of a serious infection or malignancy. The presence of a native lung is a major risk factor for lung cancer occurring in the transplant setting. Lung cancer of donor origin is rare. Bronchioloalveolar carcinoma confined to one lung can potentially be treated by transplanting the affected lung. Treatment for patients with lung cancer in the lung transplant setting has to be individualized because of the complexity of their medical problems and multiple medications. Attention needs to be focused on detecting lung cancer early in these patients to achieve a favorable outcome.

AB - With the increase in the number of lung transplants, it is expected that there will be a corresponding increase in the number of lung cancers reported in these patients. Longevity of the transplant recipients, lung transplantation for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, a history of smoking, and the increasing age of the lung donors make lung cancer more likely. Nodules and masses seen in chest imaging in lung transplant patients call for work up until a final diagnosis is achieved because there is a high likelihood of a serious infection or malignancy. The presence of a native lung is a major risk factor for lung cancer occurring in the transplant setting. Lung cancer of donor origin is rare. Bronchioloalveolar carcinoma confined to one lung can potentially be treated by transplanting the affected lung. Treatment for patients with lung cancer in the lung transplant setting has to be individualized because of the complexity of their medical problems and multiple medications. Attention needs to be focused on detecting lung cancer early in these patients to achieve a favorable outcome.

KW - Bronchioalveolar cancer

KW - Lung transplantation

KW - NSCLC

UR - http://www.scopus.com/inward/record.url?scp=67849094532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849094532&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e31819afdd9

DO - 10.1097/JTO.0b013e31819afdd9

M3 - Review article

C2 - 19349912

AN - SCOPUS:67849094532

VL - 4

SP - 753

EP - 760

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 6

ER -